BridgeBio Pharma (NASDAQ:BBIO [https://www.nasdaq.com/market-activity/stocks/bbio]), headquartered in Palo Alto, California, is a biopharmaceutical company that focuses on the creation and testing of transformative medications for genetic diseases and cancers. On Friday, October 8th, 2021, BBIO [https://unusualwhales.com/flow/ticker_flows/BBIO] saw a